Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
about
Effects of human relaxin on orthodontic tooth movement and periodontal ligaments in ratsRelaxin: antifibrotic properties and effects in models of diseaseRelaxin regulates MMP expression and promotes satellite cell mobilization during muscle healing in both young and aged mice.Solution structure and novel insights into the determinants of the receptor specificity of human relaxin-3.Trends in serum relaxin concentration among elite collegiate female athletesRelaxin regulates vascular wall remodeling and passive mechanical properties in mice.Relaxin ameliorates hypertension and increases nitric oxide metabolite excretion in angiotensin II but not N(ω)-nitro-L-arginine methyl ester hypertensive rats.Cyclic nucleotide signalling in kidney fibrosis.International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.Fibrosis in the kidney: is a problem shared a problem halved?Constitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation.Therapeutic targets in the treatment of allograft fibrosis.The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate.Relaxin as a natural agent for vascular healthRelaxin treatment of solid tumors: effects on electric field-mediated gene delivery.Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of SerelaxinThe emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts.Relaxin and its role in the development and treatment of fibrosis.Immune and inflammatory role in renal disease.Relaxin improves multiple markers of wound healing and ameliorates the disturbed healing pattern of genetically diabetic mice.Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein.Biological pathways and potential targets for prevention and therapy of chronic allograft nephropathySerelaxin for the treatment of heart failure.Anti-fibrotic actions of relaxin.Novel Anti-fibrotic Therapies.Relaxin-like bioactivity of ovine Insulin 3 (INSL3) analogues.Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosisRelaxin decreases the severity of established hepatic fibrosis in miceRelaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo.Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney.Effect of relaxin on TGF-beta1 expression in cultured vaginal fibroblasts from women with stress urinary incontinence.Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study.Relaxin-mediated renal vasodilation in the rat is associated with falls in glomerular blood pressure.The actions of relaxin on the human cardiovascular system.
P2860
Q28748277-67DFC1BB-F363-4AD6-8C91-AC27F1B917D7Q34146511-BA3E7E13-6CD1-4010-8EEC-BBA91E1D0914Q34254473-90DE1374-AA77-4C4E-98E5-2172323C28DCQ34478007-439C91E2-EB59-4E9F-A6B7-BF519091EA04Q34574131-F3156FD7-593D-45E8-830E-2D3692FF6F20Q35108756-96617C78-B8AD-4263-9D6A-0B5427BB2824Q35120364-129B441D-B178-453B-9A92-57BC120792E0Q35138860-0A190C2A-A302-43C6-83B5-C2004EDC4F7BQ35383835-F2F3D8DA-8099-4753-901F-1253F42B471EQ36012555-7600552C-35C3-41D9-A799-9C92A3012736Q36025314-D05CC4A4-1412-4DA7-90D6-29A5C44C43BBQ36447581-50456039-D56B-4804-A42C-F96F13120B57Q36749450-425235D2-FD37-4C0A-A33E-0A2317CFE781Q36835818-DDC6383D-A966-4154-B51F-26DF808A3F14Q37000549-4D711572-CAFE-4BC5-84E5-D752F80DD7D8Q37083919-2DCC8D03-CEE4-4C66-9D1B-C58A75ED1004Q37147122-DFA38189-7396-48B6-9FE9-1510A40CDF4DQ37173939-2A216C08-18BB-4F81-89CB-D41F2FEB1152Q37229308-459E8EBA-EA1C-4D87-BA3B-8CA81D2D99B2Q37243199-541B2C19-3BC3-4453-95E4-81AB995581D4Q37532442-6C642481-086C-403F-A91C-A1566B4A2E2AQ38080804-EB8F4040-207D-4777-88F6-D804F15E23AAQ38223778-85C3835A-71FB-40B5-8D90-5017B913DDE0Q38798476-96730E8A-C621-4B1A-A2C0-4B9FE9261077Q38850557-0EDCB971-3FC5-4146-AC20-A5B2E35D5D40Q39377055-BA3E96F2-A41C-4DF2-8515-B14832F97AD4Q40684572-8BE07CC3-2005-474C-9CFA-226B9BBEEF11Q41926996-D1C88908-5FCC-4284-82CA-8E068C2E123AQ42860400-A0E7C970-EBDA-43D2-B0FA-953D5309E1C4Q44487248-9201BE89-B658-48E9-B9A9-C2569B606CBFQ45859426-6760962D-59D8-4BAF-81EC-93BAF1507B1FQ46644999-853D88A0-47E3-4AC2-85D9-832D6ECE9345Q48279308-B0415EEF-BCC2-4E1A-AEDD-CD4D514909D4Q50091258-44CB9456-3FA1-41A3-A1B4-38AA56C850C8Q52851745-04317105-A994-45F6-8894-6FBBBD4A83A2
P2860
Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
@ast
Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
@en
type
label
Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
@ast
Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
@en
prefLabel
Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
@ast
Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
@en
P2093
P1433
P1476
Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
@en
P2093
Brecklin CS
Mirochnik Y
Slobodskoy L
Unemori EN
P304
P356
10.1046/J.1523-1755.2001.059003876.X
P407
P577
2001-03-01T00:00:00Z
P5875
P6179
1042513076